Next Article in Journal
Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?
Next Article in Special Issue
MicroRNAs in Uteroplacental Vascular Dysfunction
Previous Article in Journal
iNOS Interacts with Autophagy Receptor p62 and is Degraded by Autophagy in Macrophages
Previous Article in Special Issue
The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases
Open AccessReview

MicroRNAs as a Potential Quality Measurement Tool of Platelet Concentrate Stored in Blood Banks—A Review

1
Laboratory of Human Cytogenetics, Institute of Biological Sciences, Federal University of Pará, Belém, PA 66075-110, Brazil
2
Laboratory of Molecular Biology, Ophir Loyola Hospital, Belém, PA 66063-240, Brazil
3
Laboratory of Pharmacogenetics, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE 60430-275, Brazil
4
Christus University Center-Unichristus, Faculty of Biomedicine, Fortaleza, CE 60192-345, Brazil
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Cells 2019, 8(10), 1256; https://doi.org/10.3390/cells8101256
Received: 13 August 2019 / Revised: 4 September 2019 / Accepted: 10 September 2019 / Published: 15 October 2019
(This article belongs to the Special Issue Regulatory Functions of microRNAs)
Background: Platelet concentrate (PC) is one of the main products used in a therapeutic transfusion. This blood component requires special storage at blood banks, however, even under good storage conditions, modifications or degradations may occur and are known as platelet storage lesions. Methods: This research was performed on scientific citation databases PubMed/Medline, ScienceDirect, and Web of Science, for publications containing platelet storage lesions. The results obtained mainly reveal the clinical applicability of miRNAs as biomarkers of storage injury and as useful tools for a problem affecting public and private health, the lack of PC bags in countries with few blood donors. The major studies listed in this review identified miRNAs associated with important platelet functions that are relevant in clinical practice as quality biomarkers of PC, such as miR-223, miR-126, miR-10a, miR-150, miR-16, miR-21, miR-326, miR-495, let-7b, let-7c, let-7e, miR-107, miR-10b, miR-145, miR-155, miR-17, miR-191, miR-197, miR-200b, miR-24, miR-331, miR-376. These miRNAs can be used in blood banks to identify platelet injury in PC bags. Conclusion: The studies described in this review relate the functions of miRNAs with molecular mechanisms that result in functional platelet differences, such as apoptosis. Thus, miRNA profiles can be used to measure the quality of storage PC for more than 5 days, identify bags with platelet injury, and distinguish those with functional platelets. View Full-Text
Keywords: platelet concentrate; biomarkers; injury; microRNA; blood banks platelet concentrate; biomarkers; injury; microRNA; blood banks
Show Figures

Figure 1

MDPI and ACS Style

Maués, J.H.S.; Aquino Moreira-Nunes, C.F.; Rodriguez Burbano, R.M. MicroRNAs as a Potential Quality Measurement Tool of Platelet Concentrate Stored in Blood Banks—A Review. Cells 2019, 8, 1256.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop